Researchers identify “master regulator” gene that could lead to more effective treatment for patients with ovarian cancer | Newswise
In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research. A group of researchers from…